← Leaderboards
Robert J McKallip
Virginia Commonwealth University
$232,716
Attributed
$232,716
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$232,716 · 2
By mechanism
K22$152,927 · 1
F32$79,789 · 1
Top collaborators
No co-investigators on record.
Most similar at Virginia Commonwealth University
Same institution · by research overlap
- Daniel H Conrad$9,937,904
- Mitzi Nagarkatti$16,087,844
- Cynthia Nau Cornelissen$16,417,118
- Paul B Fisher$21,846,479
- Harry D Bear$5,428,734
Others in their field
Top investigators on “Blood Vessel Disorder”
- Natalia S Rost · Massachusetts General Hospital$44,124,948
- Sterling C Johnson · St. Joseph'S Hospital And Medical Center$43,216,968
- James J Lah · Emory University$37,779,951
- Rose A Gubitosi-Klug · Case Western Reserve University$34,877,235
- Paul M. Ridker · Brigham And Women'S Hospital$34,275,148
- Martin Friedlander · Scripps Research Institute$32,951,384
Research focus
Blood Vessel DisorderCd44 MoleculeCell AdhesionCytotoxicityCytotoxic T LymphocyteDisease /Disorder ModelDrug Adverse EffectGenetically Modified AnimalsImmunotherapyInterleukin 2Laboratory MouseLymphokine Activated Killer CellMonoclonal AntibodyProtein IsoformsVascular Endothelium
Grant awards (4)
The role of CD44 isoforms in immunotherapy of melanoma$152,927
K22 · FY2006 · CA · contact PI
ROLE OF CD44 ISOFORMS IN ENDOTHELIAL CELL DAMAGE$14,041
F32 · FY2002 · HL
ROLE OF CD44 ISOFORMS IN ENDOTHELIAL CELL DAMAGE$34,832
F32 · FY2001 · HL
ROLE OF CD44 ISOFORMS IN ENDOTHELIAL CELL DAMAGE$30,916
F32 · FY2000 · HL